Results 111 to 120 of about 27,788 (240)
Beni-Suef University Journal of Basic and Applied Sciences, 2014 Diabetic nephropathy is a common complication of diabetes mellitus. Transforming growth factor beta 1 (TGF-β1) is considered to be one of the major cytokines involved in the regulation of extracellular matrix (ECM) synthesis and degradation.
Yehia M. Shaker +6 more
doaj +1 more source
Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study [PDF]
, 2009 Background Patients with obesity, diabetes, and chronic kidney disease (CKD) are generally physically inactive, have a high mortality rate, and may benefit from an exercise program.
David J Leehey +8 more
core +2 more sources
Liver International, Volume 46, Issue 6, June 2026.ABSTRACT Background Previous exposure to hepatitis B virus (HBV) may influence the risk of developing hepatocellular carcinoma (HCC) and other liver‐related events (LRE), in particular in patients after HCV cure. Previous studies were not conclusive and there are only few large studies on this topic from Europe. Methods We analysed clinical endpoints (≥
Laura Muana Wilhelm +10 more
wiley +1 more source
Protein Glycation in Diabetes as Determined by Mass Spectrometry
International Journal of Endocrinology, 2013 Diabetes is a common endocrine disorder characterized by hyperglycemia leading to nonenzymatic glycation of proteins, responsible for chronic complications.
Annunziata Lapolla +2 more
doaj +1 more source
Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity
BiomoleculesAdvanced glycation end-products (AGEs) are products of a non-enzymatic reaction between amino acids and reducing sugars. Glycated human serum albumin (HSA) increases in diabetics as a consequence of elevated blood glucose levels and glycating metabolites like methylglyoxal (MGO).
Cresci-Anne C. C. Croes +6 more
openaire +3 more sources
Liver International, Volume 46, Issue 6, June 2026.ABSTRACT Background and Aim Metabolic dysfunction‐associated steatotic liver disease (MASLD) frequently coexists with type 2 diabetes (T2D) and increases cardiovascular disease (CVD) risk, with hepatic fibrosis being the main determinant of mortality.
Ilaria Barchetta +8 more
wiley +1 more source
Correlation between Serum Albumin Level and Diabetic Ketoacidosis among Children with Type I Diabetes [PDF]
International Journal of Medical ArtsBackground: Diabetic ketoacidosis [DKA] is a state of catabolism, where protein breakdown prompts decline in serum albumin levels. As a result, hypoalbuminemia could serve as a valuable indicator of the risk of ketosis, which in turn implies an ...
Dina Abouelhoda +2 more
doaj +1 more source
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. [PDF]
, 2018 ObjectiveWe examined the association of urine complement proteins with progression to end-stage renal disease (ESRD) or death in people with type 2 diabetes and proteinuric diabetic kidney disease (DKD).Research design and methodsUsing targeted mass ...
Afkarian, Maryam +6 more
core +1 more source
TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population [PDF]
, 2007 TP53, a tumor suppressor gene, has a critical role in cell cycle, apoptosis and cell senescence and participates in many crucial physiological and pathological processes.
Araujo, Lara Miguel Quirino +8 more
core +2 more sources
Advanced Science, Volume 13, Issue 28, 18 May 2026.Microproteins are hidden treasures encoded by the “dark proteome” but remain largely underexplored due to the lack of highly efficient tools. We developed a molecularly imprinted polymers (MIPs)‐based toolbox (CLAIMID) to achieve accelerated and ultrasensitive microproteins validation at multiple biological scales (single living cells, cell populations,
Hui He +10 more
wiley +1 more source